Manikay Partners LLC Invests $14.67 Million in athenahealth, Inc (ATHN) Stock

Share on StockTwits

Manikay Partners LLC bought a new position in shares of athenahealth, Inc (NASDAQ:ATHN) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 111,200 shares of the health services provider’s stock, valued at approximately $14,671,000. athenahealth comprises 1.4% of Manikay Partners LLC’s portfolio, making the stock its 22nd largest position. Manikay Partners LLC owned 0.27% of athenahealth at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Essex Savings Bank bought a new position in shares of athenahealth during the 4th quarter worth about $33,000. Larson Financial Group LLC bought a new position in shares of athenahealth during the 4th quarter worth about $40,000. Enlightenment Research LLC bought a new position in shares of athenahealth during the 4th quarter worth about $79,000. Point72 Hong Kong Ltd increased its holdings in shares of athenahealth by 1,195.2% during the 3rd quarter. Point72 Hong Kong Ltd now owns 816 shares of the health services provider’s stock worth $109,000 after purchasing an additional 753 shares during the period. Finally, Quantamental Technologies LLC bought a new position in shares of athenahealth during the 4th quarter worth about $191,000. 94.33% of the stock is owned by hedge funds and other institutional investors.

Shares of athenahealth stock opened at $134.99 on Monday. The company has a current ratio of 2.74, a quick ratio of 2.74 and a debt-to-equity ratio of 0.22. The stock has a market cap of $5.48 billion, a price-to-earnings ratio of 85.98, a PEG ratio of 2.41 and a beta of 0.75. athenahealth, Inc has a 1-year low of $116.77 and a 1-year high of $163.94.

A number of analysts recently weighed in on ATHN shares. BidaskClub cut shares of athenahealth from a “sell” rating to a “strong sell” rating in a research note on Thursday, February 7th. Morgan Stanley upped their target price on shares of athenahealth from $128.00 to $135.00 and gave the company an “equal weight” rating in a research note on Monday, December 3rd. ValuEngine cut shares of athenahealth from a “buy” rating to a “hold” rating in a research note on Wednesday, January 9th. Finally, Wells Fargo & Co cut shares of athenahealth from an “outperform” rating to a “market perform” rating and set a $135.00 target price on the stock. in a research note on Tuesday, November 27th. One equities research analyst has rated the stock with a sell rating, nineteen have issued a hold rating and three have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $147.75.

TRADEMARK VIOLATION WARNING: This report was posted by Week Herald and is the property of of Week Herald. If you are reading this report on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The original version of this report can be viewed at https://weekherald.com/2019/03/18/manikay-partners-llc-invests-14-67-million-in-athenahealth-inc-athn-stock.html.

athenahealth Company Profile

athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.

Recommended Story: Different Options Trading Strategies

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.